1. Home
  2. EXFY vs ALEC Comparison

EXFY vs ALEC Comparison

Compare EXFY & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expensify Inc.

EXFY

Expensify Inc.

HOLD

Current Price

$2.32

Market Cap

217.0M

Sector

Technology

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.97

Market Cap

275.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXFY
ALEC
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
217.0M
275.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
EXFY
ALEC
Price
$2.32
$1.97
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$4.50
$4.83
AVG Volume (30 Days)
541.7K
1.2M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$142,101,000.00
$21,045,000.00
Revenue This Year
$0.42
$2.03
Revenue Next Year
$0.11
$29.87
P/E Ratio
N/A
N/A
Revenue Growth
2.06
N/A
52 Week Low
$0.69
$1.09
52 Week High
$2.81
$3.40

Technical Indicators

Market Signals
Indicator
EXFY
ALEC
Relative Strength Index (RSI) 49.22 45.59
Support Level $2.04 $1.93
Resistance Level $2.42 $2.10
Average True Range (ATR) 0.11 0.19
MACD -0.03 -0.07
Stochastic Oscillator 50.50 21.13

Price Performance

Historical Comparison
EXFY
ALEC

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app. Small and medium-sized businesses (SMBs) are the cornerstone of the global economy, making up almost all businesses and the majority of employment in Organization for Economic Co-operation and Development (OECD) member countries.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: